Gilead to Donate Remdesivir for Emergency Use Against Marburg Disease in Rwanda
Gilead Sciences said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical Supply for emergency use in response to the Marburg virus outbreak. The drug is being supplied in conjunction with Rwanda's health ministry and the Africa Centers for Disease Control,